Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07443332 · ClinicalTrials.gov registry record · NA
Culturally Adapted Contingency Management
A NA study, sponsored by Yale University.
- Not yet
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT07443332: Clinical Trial NA study, sponsored by Yale University.
NCT07443332 is a NA study that has not yet begun recruiting, run by Yale University. The registered enrollment target is 70 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07443332, a NA study, has not yet begun recruiting, sponsored by Yale University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
The purpose of this study is to develop a culturally adapted contingency management (CM) protocol for Black adults with stimulant use disorder.
Primary Outcome
Participants will provide urine samples twice weekly. Percent of negative urines provided will be calculated.
Interventions
- BEHAVIORAL Cultually Adapted Contingency Management (CM)
- BEHAVIORAL Basic Contingency Management (CM)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2028-07 |
| Est. Completion | 2030-03 |
| Phase | NA |
What is known before NCT07443332 opens enrollment
NCT07443332 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Cultually Adapted Contingency Management (CM) is the first listed.
NCT07443332 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07443332 about?
NCT07443332 is a clinical study titled "Culturally Adapted Contingency Management". The purpose of this study is to develop a culturally adapted contingency management (CM) protocol for Black adults with stimulant use disorder.
What is the current status of trial NCT07443332?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2028-07. Estimated completion is 2030-03.
What interventions are being tested in trial NCT07443332?
The interventions under investigation include: Cultually Adapted Contingency Management (CM) (BEHAVIORAL), Basic Contingency Management (CM) (BEHAVIORAL).
Who is sponsoring clinical trial NCT07443332?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07443332's enrollment target sits among peer trials
70 1103rd of 2000 higher than 868 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia